InsidersTradesSigma
Browse the complete record of transactions filed by Swartz Robin. Director active across 1 company, notably Voyager Therapeutics, Inc.. Cumulatively, 2 reports have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €44k. Activity tracked since 21 March 2022. The latest transaction was filed on 4 April 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations